Melissa Easy and Vinita Navadgi of IQVIA discuss the advantages of automating consent workflows in healthcare through eConsent processes. They delve into the metrics defining its effectiveness, highlight the role of AI in shaping clinical trials, and explore the potential of using AI tools to personalize consent-related content for better patient outcomes.

Melissa Easy and Tim Riely of IQVIA talk about the current state of AI in life sciences and clinical trials. They discuss overcoming challenges in clinical trials during the pandemic with the help of AI technologies. They also highlight the challenges of applying AI in clinical trials and explore ways to reduce patient burden and design effective trials. The impact of AI-enhanced clinical trials on patient experiences is discussed, emphasizing the need for easy patient journeys and diversity in representation.